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Abstract: Melanoma is the most aggressive skin cancer type. It is 
characterized by pigmented lesions with high tissue invasion and metastatic 
potential. The early detection of melanoma is extremely important to 
improve patient prognosis and survival rate, since it can progress to the 
deadly metastatic stage. Presently, the melanoma diagnosis is based on the 
clinical analysis of the macroscopic lesion characteristics such as shape, 
color, borders following the ABCD rules. The aim of this study is to 
evaluate the time-resolved fluorescence lifetime of NADH and FAD 
molecules to detect cutaneous melanoma in an experimental in vivo model. 
Forty-two lesions were analyzed and the data was classified using linear 
discriminant analysis, a sensitivity of 99.4%, specificity of 97.4% and 
accuracy of 98.4% were achieved. These results show the potential of this 
fluorescence spectroscopy for melanoma detection. 
© 2014 Optical Society of America 
OCIS codes: (300.6500) Spectroscopy, time-resolved; (170.3650) Lifetime-based sensing; 
(170.3890) Medical optics instrumentation; (170.6510) Spectroscopy, tissue diagnostics; 
(170.6935) Tissue characterization. 
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1. Introduction 
Annually, 2-3 millions non-melanoma and around 132,000 melanoma skin cancers occur 
globally and, unfortunately, these numbers are increasing, according to the World Health 
Organization. Surgical resection is only effective for initial lesions, and its recurrence can 
vary from 7 to 51%. In Brazil, approximately 6,000 lesions are diagnosed per year, and 
melanoma is responsible for 80-85% of all deaths caused by skin cancer. Melanoma is the 
most aggressive skin cancer type, which is characterized by pigmented lesions with high 
metastatic potential. The early detection of melanoma is extremely important to improve 
patient prognosis and decrease mortality rate. Presently, the melanoma diagnosis is based on 
the clinical analysis of the macroscopic lesion characteristics such as shape, color, borders 
following the ABCD rule. The ABCD rule states for: A (asymmetry), B (border irregularity), 
color (non-homogenous color distribution), and D (diameter greater than 6 mm). The lesion 
progression and site location are also considered for clinical diagnosis [1]. 
As soon as the clinical examination indicates a potential melanoma, an excision is 
performed and then, the histology is evaluated. If melanoma cells are detected in the border of 
the lesion, another excision is performed with a larger resection margin. Chemotherapy and 
radiotherapy are also indicated for the cases of possible metastatic stage [2]. Anyway, early 
detection of melanoma is highly dependent on the clinician training and expertise on 
recognizing initial melanoma signs. Optical techniques for diagnosis have been already used 
for melanoma detection such as epiluminescence microscopy, reflectance spectrophotometry, 
fluorescence spectroscopy, fluorescence imaging and optical coherence tomography [3, 4]. 
Melanoma cells are characterized by high proliferative and metabolic rates, but the most 
common variation between normal and cancer cells is the high rate of aerobic glycolysis or 
the Warburg effect. The Warburg effect describes the cancer respiratory pathway that, when 
in the presence of oxygen, shows a high rate of glycolysis, followed by the lact acid 
fermentation in citosol, in contrast to the normal cells that present a lower glycolysis rate, 
followed by oxidation of pyruvate in mitochondria. In normal tissue, the glucose metabolism 
pathway is described by the Pasteur Effect, which determines the metabolism pathway with 
plentiful and limited oxygen [5, 6]. NADH (nicotinamide adenine dinucleotide) and FAD 
(flavin adenine dinucleotide) are the primary electron acceptor and donor, respectively, in 
oxidative phosphorylation, the most efficient means of energy production in cells. Changes in 
the NADH/FAD rates and their relative amounts of free and protein-bound states depend on 
the glycolysis and oxidative phosphorylation ratio. This suggests that tissues with different 
metabolic rates can be discriminated by comparing short and long lifetime fluorescence 
decays of NADH (the average lifetimes for free and protein-bound NADH are approximately 
0.3 ns and 2 ns, respectively) and FAD (for free FAD is around 5 ns and, for protein-bound 
FAD, approximately 1 ns) and the relative amount of free and protein-bound states [7]. 
Although NADH and FAD are the mainly molecules used as biomarkers for tumor 
metabolism, the fluorescence lifetime technique reveals changes in the tumor 
microenvironment, and is influenced by others fluorophores present in tissue. The individual 
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fluorescence analysis of specific molecules in tissue measurements is a complex task, since 
the overall spectrum presents the contribution of several biomolecules, including absorbers 
and scatterers, and is modified by attenuation coefficient at the visible spectrum. Anyway, the 
detection of these overall changes in tumor microenvironment is an important factor for tumor 
and margin evaluation. 
Fluorescence lifetime analysis has been presented as a sensitive technique for tissue 
characterization for diagnosis purposes. The fluorescence lifetime can discriminate free and 
protein-bound components of fluorophores. One of the main advantages of the fluorescence 
techniques is the in situ and non-destructive evaluation of tissues with fast response. This 
makes the fluorescence lifetime technique quite suitable for clinical applications. Targeting 
NADH and FAD from cutaneous melanoma lesions may present diagnostic information. The 
aim of the present study is to evaluate the efficacy of the time-resolved fluorescence 
spectroscopy on the diagnostics of the induced cutaneous melanoma in an animal model. 
2. Materials and methods 
Cell line: The B16F10 murine melanoma cells (Rio de Janeiro Cell Bank, Rio de Janeiro, 
Brazil) were cultured in DMEM medium supplemented with 10% bovine fetal serum and 1% 
penicillin-streptomycin solution under 5% CO2 at 37°C. 
Animals: Forty-two nude balb/c mice (Centro de Bioterismo - Universidade de São Paulo 
– São Paulo, Brasil) were housed in micro-isolator cages, with food and water ad libitum. 
Experimental melanoma: The animal was anesthetized using 2% isofluorane mask. An 
intradermal injection of 10
7
 B16F10 cells in 100 µL of PBS was performed into the right and 
left animal flank regions. The mice were examined daily to monitor any changes in systemic 
conditions as loss of weight or signs of metastasis. This study was approved by the Ethical 
Committee of the Universidade Federal de São Carlos – São Carlos/Brazil. 
Characterization of optical properties of the experimental melanoma: The light 
distribution in the induced tumor was evaluated by reflectance, fluorescence and transmission 
spectroscopy measurements. For the reflectance and fluorescence measurements, the optical 
fiber coupled to 378nm or 445nm laser was positioned on the top of the tumor, and the 
reflectance was radially collected scanning the total lesion surface, or until the signal absence, 
in steps of 0.1mm. Then, the animal was euthanized and the tumor was removed for 
transmittance evaluation. For experimental purposes, an optical fiber was positioned at the top 
of the lesion, and the collect fiber was positioned at the tumor base to collect the transmission 
light. The diffuse and transmitted reflectance spectra were plotted and the total attenuation 
coefficients were determined based on the dimensional lesion characteristics. Fluorescence 
spectra were also plotted and the maximum distance at the lesion surface from the excitation 
site was determined. Based on these measurements, an estimated interrogated tissue volume 
for this experimental melanoma was defined. 
Fluorescence system: The time-resolved fluorescence spectroscopy system is composed of 
two diode lasers, one emitting at 378 nm and another at 445 nm (BDL-375-SMC and BDL-
445-SMC, Becker and Hickl, Berlin, Germany). The 378 nm is used to excite NADH, and the 
445 nm to excite FAD. Both lasers have a repetition rate of 20, 50, 80 MHz and a temporal 
pulse duration of 50-100 ps. A bifurcated fiber (Ocean Optics, Dunedin, Florida, USA) was 
used to deliver the light to the tissue and to collect the tissue fluorescence. A bandpass filter at 
(440 ± 40) nm (Semrock, Rochester, New York, USA) was used with 378 nm excitation, and 
a bandpass filter at (514 ± 30) nm (Semrock, Rochester, New York, USA), for 445 nm 
excitation. The fluorescence signal was detected using a high-speed hybrid PMT detector 
(HPM-100-50, Becker and Hickl, Berlin, Germany). The data were collected and processed 
using the TCSPC Software (Becker and Hickl, Berlin, Germany). The impulse response 
function (IRF) of the system is about 230 ps. 
Fluorescence lifetime measurements: Lesions of 2 up to 30 mm in diameter were 
interrogated. The mice were anaesthetized with 2% isourane in oxygen using a mask. The 
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optical fiber was positioned at the surface of the experimental melanoma lesion or on the 
normal skin and the fluorescence measurements were collected. At least three measurements 
were taken from each lesion with both excitation lasers. Each flank region where the 
melanoma cells were inoculated was monitored daily, and the measurements were performed 
with lesions size between 2 and 15mm. A total of 42 lesions were investigated. 
Data processing: The raw data of the photon counting with time resolution was processed 
using the SPCImage Software (Becker and Hickl, Berlin, Germany). SPCImage software 
provides an “estimation” of the IRF by calculating the first derivative of the rising part of the 
fluorescence lifetime spectrum and, then, it calculates a function model for the measured 
intensity by the convolution of the IRF and the exponential decay fitting. So, the decay curve 
of the model function was fitted by a bi-exponential function: 
   1 21 2 , 
t t
τ   τ  
F t a e a e    [1] 
using the average fluorescence lifetime values τ1 and τ2, ccorresponding to short and long 
lifetime components, respectively, and relative coefficients a1 and a2, where a1 + a2 = 100. 
In order to compare the collected data from normal skin and cutaneous melanoma, scatter 
plots and box plots graphs were constructed using Origin 9.0 (OriginLab. Corporation, 
Northampton, MA, USA) using a1, a2, τ1 and τ2 parameters of each measurement. This 
comparison allowed a better discrimination for measurements using 378 nm or 445 nm 
excitation wavelengths. 
Statistical analysis: It was used unpaired t test. Exact p values were computed, all p values 
are two-sided, and a p ˂0.001 was considered statistically significant. 
Data analysis: a classification was performed with the linear discrimination analysis of 
MATLAB software (version R2012a, Mathworks, Natick, MA, USA) to determine the 
combination of predictor variables that accounts for most of the differences in the behaviors 
of the normal skin and cutaneous melanoma groups. The classification algorithms were then 
evaluated based on sensitivity, specificity and accuracy values. For diagnostics classification, 
histopathology of HE slides was used as gold standard. 
3. Results 
Experimental melanoma: the induced cutaneous lesion shows a fast progression characterized 
by dark pigmentation and metastatic potential. Twenty-four hours after the injection it is 
possible to observe a small pigmented lesion with an average of 2-3mm in diameter. At 48 
hours after the melanoma induction, the lesions reach up to 1cm of diameter. After 7 days, the 
tumor shows a diameter of 4-5cm. During this development, no significant changes were 
observed in the animal overall conditions, as loss of body weight or changes in behavior. Ten 
days after the induction, metastasis can be observed. In the first 48 hours of development, 
some lesions present a thin layer of normal epidermis over the tumor. It constitutes a 
limitation for optical measurements such as fluorescence lifetime, especially with ultraviolet-
violet excitation, since the detected signal has also the contribution of normal tissue presented. 
The induced lesion rises at the surface until approximately 72 hours, becoming similar to a 
spontaneous lesion. After 10 days it starts to invade deeper tissues, reaching muscle and 
spreading to all the body. Even before invasion, the lesion area observed on the skin surface 
was smaller than that observed in dermis deeper layers. During this period, angiogenesis is 
also observed, but this is not sufficient to feed the whole tumor mass and the lesion center 
become necrotic. For experimental purposes, no measurements were performed in the 
necrosis area, due to the absence of lesion diagnostic information. In the histology one can 
observe melanoma cells surrounded by a collagen fiber and numerous blood vessels. 
Characterization of experimental melanoma optical properties: the 378nm laser 
reflectance measurements showed that the light is completely absorbed by the tissue and so, 
no reflectance was observed at the surface. On the other hand, it was possible to observe the 
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tissue fluorescence as a function of the radial distance. The decays were fitted and the 
attenuation coefficient determined. Then, an interrogated volume was estimated in about 
0.079 ± 0.009 mm
3
. For the 445nm laser, due to its low efficiency for tissue excitation, it was 
not possible to detect the fluorescence signal. However, the reflectance measurements were 
enough to estimate the probed volume to 0.017 ± 0.002 mm
3
. Due to the lesion thickness 
between 2.4mm and 4mm, transmittance signal was not detected for none excitation lasers. 
Time-resolved fluorescence lifetime spectra: the fluorescence lifetime is sensitive to 
fluorophore microenvironment and provides a method for discriminating free and protein-
bound components of NADH and FAD. The NADH molecules show a short lifetime 
component when it is free and a longer lifetime component when it is protein-bounded. For 
FAD molecules, short lifetime component is present for protein-bounded and longer lifetime 
component for its free state. These molecules states are related to aerobic and anaerobic 
processes: oxidative phosphorylation and glycolysis. In Fig. 1 one can observe the decay 
curve for (mainly) NADH and FAD molecules in normal skin and melanoma. 
 
Fig. 1. Representative fluorescence decay profiles of NADH (A) and FAD (B) molecules in 
normal skin and melanoma. 
Despite the fact that the system excites targeting NADH and FAD molecules, it is 
complex to evaluated individually the contribution of these molecules in the in vivo 
fluorescence spectrum. Other biomolecules also contribute for the collected spectrum such as 
melanin, collagen, elastin and keratin. 
Data processing: The results obtained for the 378nm excitation is shown in Fig. 2. One can 
observe that for the a1 and a2 parameters there were no significant difference between normal 
skin and cutaneous melanoma (Fig. 2(A) and 2(B)). It was not observed in the melanoma, 
probably due to the thin normal epidermis layer present over the experimental lesion. In 
addition to its contribution to the collected fluorescence signal, this thin skin layer also 
reduces the laser penetration and resulted excitation of the target tissue. 
On the other hand, the parameters τ1 and τ2 that refers to the average lifetime fluorescence 
values showed a statistical significant discrimination between normal skin and melanoma (p < 
0.001)(Fig. 2(C) and 2(D)). Both, short and long lifetime components, increased in melanoma 
when compared to normal skin. If the results agreed with the Warburg effect, the melanoma 
fluorescence lifetime would be diminished due to the presence of higher concentration of free 
NADH molecules when compared to protein-bound molecules. However, this was not 
observed. A hypothesis to these results is that since we interrogated the melanoma lesions at 
different development stages, the specific Warburg effect could not be observed at the 
average data. Furthermore, others molecules such as collagen and melanin may contribute to 
this change in the fluorescence lifetime observed. This data was also fitted for three 
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exponentials, but the parameters obtained did not improve our results. Anyway, these 
measurements showed a significant discrimination between normal skin and melanoma. 
 
Fig. 2. Boxplot for the parameters obtained in the data analysis for 378 nm excitation: a1, a2, τ1 
and τ2, respectively. Significant differences (P < 0.001) exist between normal vs. melanoma for 
the parameters τ1 and τ2(*). 
Figure 3 shows the fluorescence lifetime parameters obtained for FAD excitation at 
445nm. The parameters a1 and a2 represent the relative quantities of FAD molecules on both 
states, protein-bound and free, respectively. Figure 3(A) and 3(B) show that melanoma has 
more FAD in protein-bound state than normal skin. The opposite is also true: normal skin has 
more free FAD molecules than melanoma. If the glycolysis and oxidative phosphorylation 
ratio characteristic of melanoma were observed, melanoma would present higher amount of 
free FAD than in normal tissue. However, looking for the normal skin, the relative quantities 
of free and protein-bound FAD agree with the aerobic metabolism. These results may be 
explained by the system used for the measurements. Although FAD is the mainly excited 
molecule, it is not the unique one. 
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 Fig. 3. Boxplot for the parameters obtained in the data analysis for 445 nm excitation: a1, a2, τ1 
and τ2, respectively. Significant differences (P < 0.001) exist between normal skin vs. 
melanoma for all parameters (*). 
The protein-bound FAD is part of the oxidative phosphorylation metabolism and its 
lifetime is smaller when compared to the free FAD state. Therefore, the short and long 
lifetime components describe the melanoma preference to glycolysis (Fig. 3(C) and 3(D)). 
These results agree with the melanoma metabolism changes described by Scott et al., 2011 
[6]. Melanoma, even in the presence of oxygen, increases the energy generation by 
nonoxidative breakdown of glucose – glycolysis, instead of more energy-efficient oxidative 
respiration. 
Data analysis: The data classification was performed using the parameters τ1 for 445 nm 
excitation and τ2 for 378 nm. These parameters were chosen based on the best results obtained 
in this study. The linear discriminant analysis was able to discriminate normal skin and 
melanoma with a sensitivity of 99.4%, specificity of 97.4% and accuracy of 98.4% (Fig. 4). 
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 Fig. 4. Short lifetime component (τ1) of 445 nm excitation against long lifetime component (τ2) 
of 378 nm, the separating lines was performed using linear discrimination analysis. 
The short lifetime component of FAD and long lifetime component of NADH provides 
information about the oxidative phosphorylation metabolism pathway. The aerobic respiration 
is present in both tissues following the Pasteur effect. Furthermore, it was an important 
parameter to distinguish normal skin and melanoma. 
4. Discussion 
Metabolism is an important parameter to evaluate the cell microenvironment. Nicotinamide 
adenine dinucleotide (NAD
+
/NADH) is an important coenzyme involved in the energy 
metabolism of living cells. In the aerobic respiration, glucose is converted to lactate, NADH is 
oxidized to generate ATP through oxidative phosphorylation. NADH has a short and a long 
lifetime components, depending on whether it is in free or protein-bound state, respectively 
[6]. 
FAD is another coenzyme in living systems and is also present in two forms, referred to as 
protein-bound and free FAD. The protein-bound FAD state participates in oxidative 
phosphoylation and it is also important for tumor metabolism [6]. FAD also has, short and 
long lifetime components refer to protein-bound and free FAD state, respectively. Changes in 
the tumor’s microenvironment such as the oxygen viability, pH, and temperature modify the 
metabolism process, and may be detected by time-resolved fluorescence lifetime 
measurements. 
Results obtained in experimental melanoma model with excitation at 378nm were able to 
distinguish normal skin and tumor for both lifetime components. However, parameters a1 and 
a2 were not able to distinguish normal skin and melanoma. These components are related to 
the amount of NADH molecules in the free and protein-bound states and the measurements 
may be compromised due to the experimental melanoma development. A thin normal 
epidermis can be observed overlaying the melanoma lesion in the first three days after the 
cells injection. This tissue layer probably contributes to the amount of NADH measurements 
modifying the parameters a1 and a2. It also influences the long and short lifetime components, 
but it is not visible due to the average lifetime obtained. Therefore, both lifetime components 
distinguished the normal skin and melanoma. These results do not agree with the Warburg 
Effect that describes the tumor metabolism preference to glycolysis (Scott et al., 2011). If it 
happens, melanoma would present lower fluorescence lifetimes due to the free NADH state 
lifetime contribution. There are many reasons that may explain this, such as experimental 
melanoma development, tumor pH and oxygen. Some endogenous fluorophores such as 
tryptophan moieties, collagenase-digestible and pepsin-digestible collagen, cross-links, elastin 
cross-links, reduced NADH, oxidized flavins, porphyrin and keratin may contribute to change 
the NADH fluorescence lifetime in melanoma. Several studies using fluorescence lifetime 
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presented different behaviors for normal and malignant tissues that are neither all in 
agreement with the Warburg effect. Skala et al. (2007) evaluated the fluorescence lifetime in 
precancerous epithelia and showed a decrease in the NADH lifetime when comparing normal 
to low and high grade precancerous [8]. 
The experiments performed with the 445nm excitation showed statistical significance for 
all components evaluated. Melanoma presented a higher amount of protein-bound state FAD 
in comparison to normal skin. It does not reveal the expected, wherein the protein-bound state 
FAD is related to the oxidative phosphorylation metabolism. Although the relative quantities 
of FAD did not agree with the Warburg effect, the opposite was observed for the lifetimes. 
The protein-bound FAD state has a short lifetime, while the free FAD has a long lifetime. 
Results showed that the melanoma has a longer lifetime, related to the presence of free FAD 
molecules. On the other hand, the normal skin showed a shorter lifetime, related to the 
protein-bound FAD. These results agree with the tumor preference to glycolysis. pH is 
another parameter that may influence the FAD lifetime. Islam et al. (2013) described that 
acidic pH shift the fluorescence lifetime to higher values, while basic pH shifts the 
fluorescence lifetime to smaller values [9]. This shift to higher lifetime values was observed 
in melanoma measurements, and it may be related to the pH effect once there are several 
studies describing the melanoma acidic characteristic [10,11]. Our results based on an 
averaged of the fluorescence lifetime measured at distinct melanoma development stages may 
not be specifically explained by the Warburg effect. The analysis of the NADH and FAD, free 
and protein-bound states, has not been completely elucidated during at each step of the tumor 
development. Tumor metabolic pathways is a complex process involving many factors such 
as cell type and proliferation rate, temperature, experimental model including the animal and 
others [12]. Beyond that, it is not possible to measure the fluorescence lifetime of only NADH 
and FAD molecules. They are the mainly molecules present in tissue, but collagen, melanin, 
keratin and others molecules can be find and definitely contribute to the fluorescence lifetime. 
Tumor metabolic stages and the amount of molecules present in tissue may be the responsible 
of changes in the decays. 
Butte et al. (2005) described the potential use of time-resolved fluorescence spectroscopy 
as an adjunctive tool for the intraoperative rapid evaluation of meningioma diagnosis. They 
evaluated the technique on ex vivo tissue specimens from patients undergoing brain tumor 
surgery and the results showed a sensitivity higher than 89%, specificity of 100% and an 
accuracy of classification around 92% [13]. 
Marchesini et al. (2002) reviewed the most important optical systems for melanoma 
detection. Video camera showed specificity from 55 to 91%, sensitivity from 80 to 90%. The 
best results were obtained for infrared and RGB gradient color [3, 14, 15]. Spectrophotometry 
techniques showed specificity from 46 to 91% and sensitivity from 80 to 89%. The best 
results were obtained for lesion area and spectral curve analysis [16]. Elbaum et al. 2001 
investigated the potential of the multispectral dermoscopy to diagnose melanoma. Sixty-three 
cutaneous melanoma and 224 non-melanoma lesions were evaluated. In this study, the 
infrared and wavelet data were evaluated and 85% specificity and 100% sensitivity were 
obtained [17]. 
Multiphoton laser tomography and fluorescence lifetime was also evaluated for melanoma 
[4]. This technique was able to distinguish cell morphology such as keranocytes and 
melanocytes, although this technique did not distinguish melanoma and nevus. 
The main advantage of time-resolved fluorescence lifetime comparing with steady-state 
fluorescence spectroscopy is the possibility to obtain metabolic information that is not 
dependent on tissue absorption and scattering [8]. This advantage is highly important for 
melanoma. It is also important for margin detection during a surgery resection. 
Using the time-domain fluorescence lifetime, our results showed a sensitivity of 99.4%, 
specificity of 97.4% and accuracy of 98.4% when it was used a linear classification. These 
results refer to 42 experimental melanoma lesions induced in balb/c nude mice using the cell 
#214104 - $15.00 USD Received 16 Jun 2014; revised 8 Aug 2014; accepted 10 Aug 2014; published 22 Aug 2014
(C) 2014 OSA 1 September 2014 | Vol. 5,  No. 9 | DOI:10.1364/BOE.5.003080 | BIOMEDICAL OPTICS EXPRESS  3088
line B16F10. Though these results were obtained with an experimental melanoma, the values 
of sensitivity, specificity and accuracy were significant when compared to other techniques. 
Despite this study reveals that the fluorescence lifetime technique was able to distinguish 
normal and melanoma tissue, its potential use for melanoma and margins diagnostics must be 
defined based also on the discrimination of melanoma and others pigmented lesions.The 
investigation of the efficacy of this technique in cutaneous pigmented lesions will be 
performed in patients. Anyway, the differentiation of normal skin and melanoma is very 
important for margin detection in surgery, once melanoma is an extremely aggressive tumor 
with high rates of morbidity and mortality when metastasized. The possibility of using a fast 
measurement to determine the tumor site ressection may reduce the recurrence rate and then, 
improve the patient survival. 
5. Conclusion 
High rates of sensitivity, specificity, and accuracy of 99.4%, 97.4%, 98.4%, respectively, 
were obtained using time-domain fluorescence spectroscopy to detect cutaneous melanoma in 
an animal model. These results show the potential of lifetime fluorescence to aid in the 
cutaneous melanoma detection through a non-invasive technique. 
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